Christopher Roth

Company: Abilita Therapeutics

Job title: Vice President Of Research

Seminars:

Advancing the Optimization of Lead Biologic Candidates using New Screening Platforms 2:10 pm

What is the workflow to screening for highly specific biologics How to enhance binding affinity of anti-GPCR antibodies with chemical optimization? How to exploit the druggability of antibodies to target previously undrugged GPCRs?Read more

day: Day One Track B PM

Roundtable Discussion: Leading Deorphanization with the Identification of Endogenous Ligands as a Compound to Advance Rationale Drug Development 3:30 pm

How to validate proposed true orphan GPCR-ligand pairs and with what suite of assays? What are the emerging methods for accomplishing deorphanization? Structural characterization, Mass spec etc   How to reveal the therapeutically relevant signaling pathways activated by orphan GPCRs?  Read more

day: Day One PM